PhalconBio GmbH
PrivateLast Round
Grant
Feb 18, 2025
Company Overview
PhalconBio GmbH operates in Healthcare & Life Sciences and is based in Wädenswil.
PhalconBio GmbH is a biotechnology company that develops antimicrobial precision medicines using engineered bacteriophages to combat antibiotic resistance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PhalconBio GmbH Comparables
Compare PhalconBio GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Paralos Bioscience | 83% | |
| PhageOne | 81% | |
| Locus Biosciences | 81% |
For institutional investors. Book with your work email.
PhalconBio GmbH Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
PhalconBio GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| PACE (Pathways to Antimicrobial Clinical Efficacy) | Grant |
| Innovate UK | Grant |
| Medicines Discovery Catapult | Grant |
| LifeArc | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors increased 1251% MoM, reaching 1.3K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingOct 7, 2026
At its Sep 1st '26 Selection Committee Meeting in Switzerland, INCATE awards Stage II funding to PhalconBio, which is to receive $281K and company-building support to advance its Dual-Action Phage program.
For institutional investors. Book with your work email.
PhalconBio GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PhalconBio GmbH's valuation, stock price, and market status.
Is PhalconBio GmbH a public or private company?
PhalconBio GmbH is a private company.
What is the current stock price of PhalconBio GmbH?
PhalconBio GmbH is a private company, so its shares have no public market price. Caplight tracks PhalconBio GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PhalconBio GmbH worth (valuation)?
Valuation information for PhalconBio GmbH is not publicly available.
Can I buy PhalconBio GmbH stock?
PhalconBio GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PhalconBio GmbH's last funding round?
PhalconBio GmbH's most recent funding round was Grant on February 18, 2025.
Who are the main investors in PhalconBio GmbH?
Key investors in PhalconBio GmbH include PACE (Pathways to Antimicrobial Clinical Efficacy).
Will PhalconBio GmbH IPO soon?
No public IPO plans have been announced for PhalconBio GmbH.
How can I track PhalconBio GmbH secondary market activity?
Caplight tracks bids, offers, and trades in PhalconBio GmbH's shares on secondary markets.